Neuro42 is a biotechnology company focused on developing therapies for neurological disorders. Using innovative research platforms and translational biology, Neuro42 aims to discover and advance treatments that address unmet needs in neurodegenerative and neuropsychiatric diseases, improving patient outcomes and quality of life.